PharmaResearch Co., Ltd. (KOSDAQ:214450)
South Korea · Delayed Price · Currency is KRW 413,500
+22,500 (5.75%)
Aug 20, 2026, 3:30 PM KST
PharmaResearch Stock Forecast
Stock Price Forecast
According to 14 analysts polled by S&P Global, PharmaResearch stock has a consensus rating of "Buy" and an average price target of ₩508,357. The average 1-year stock price forecast is 22.94% higher than the current stock price, while the lowest is ₩390,000 (-5.68%) and the highest is ₩647,000 (+56.47%).
Price Target: ₩508,357 (+22.94%)
Analyst Consensus: Buy
Price Target
ChartAnalyst Ratings
The average analyst rating for PharmaResearch stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Mar '26 | Apr '26 | May '26 | Jun '26 | Jul '26 | Aug '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 7 | 7 | 7 | 8 | 8 | 8 |
| Buy | 6 | 6 | 6 | 5 | 5 | 5 |
| Hold | 1 | 1 | 1 | 1 | 1 | 1 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 14 | 14 | 14 | 14 | 14 | 14 |
Financial Forecast
Revenue This Year
701.10B
from 536.29B
Increased by 30.73%
Revenue Next Year
835.20B
from 701.10B
Increased by 19.13%
EPS This Year
19.84K
from 14.93K
Increased by 32.87%
EPS Next Year
23.58K
from 19.84K
Increased by 18.86%
EPS and Forward PE are based on non-GAAP adjusted numbers. Financial currency is KRW.